Insulin aspart: A novel rapid-acting human insulin analogue

Expert Opinion on Investigational Drugs

Volumn 8, Issue 9, 1999, Pages 1431-1442

  Gammeltoft, S ^a   Hansen, B F ^a   Dideriksen, L ^a   Lindholm, A ^a   Schaffer, L ^a   Trub, T ^a   Dayan, A ^a   Kurtzhals, P ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Glycaemic control; HbA(1c); Hypoglycaemia; IGF I receptor; Insulin analogue; Insulin aspart; Insulin receptor; Mitogenicity; Pharmacokinetics; Toxico pharmacology

Indexed keywords

INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN RECEPTOR; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CARCINOGENICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ABSORPTION; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; META ANALYSIS; METABOLIC REGULATION; MITOGENESIS; NONHUMAN; QUALITY OF LIFE; RAT; RECEPTOR AFFINITY; REVIEW;

EID: 0032867985     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.8.9.1431     Document Type: Review

References (46)